1. Cha, Hyun Ju, Eum, Won Sik, Youn, Gi Soo, Shin, Min Jea, Choi, Soo Young. . Tat-Thioredoxin-like protein 1 attenuates ischemic brain injury by regulation of MAPKs and apoptosis signaling. In BMB reports, 56, 234-239. doi:. https://pubmed.ncbi.nlm.nih.gov/36571143/
2. Ni, Pan, Xu, Wenxia, Zhang, Yajie, Xu, Shan, Zhou, Jianwei. . TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines. In Current cancer drug targets, 14, 850-9. doi:. https://pubmed.ncbi.nlm.nih.gov/25348020/
3. Andersen, Katrine M, Madsen, Louise, Prag, Søren, Hendil, Klavs B, Hartmann-Petersen, Rasmus. 2009. Thioredoxin Txnl1/TRP32 is a redox-active cofactor of the 26 S proteasome. In The Journal of biological chemistry, 284, 15246-54. doi:10.1074/jbc.M900016200. https://pubmed.ncbi.nlm.nih.gov/19349277/
4. Dilshan, M A H, Omeka, W K M, Udayantha, H M V, Wan, Qiang, Lee, Jehee. 2023. Molecular features, antioxidant potential, and immunological expression assessment of thioredoxin-like protein 1 (TXNL1) in yellowtail clownfish (Amphiprion clarkii). In Fish & shellfish immunology, 141, 109009. doi:10.1016/j.fsi.2023.109009. https://pubmed.ncbi.nlm.nih.gov/37598735/
5. Xu, W, Wang, S, Chen, Q, Zhang, R, Zhou, J. 2014. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer. In Cell death & disease, 5, e1055. doi:10.1038/cddis.2014.27. https://pubmed.ncbi.nlm.nih.gov/24525731/